One possible mechanism of the malignant evolution of IPMN, in light of our findings and existing literature, is that the expression of CD55, promoted by the immunosuppressive cytokine, interleukin-4, prevents complement-dependent cytotoxicity in cancer cells, which consequently accelerates the malignant transformation of IPMN dysplasia [61,62]. The gene discussed is CD55; the disease is cancer.